Christopher Hansen, MD
Dermatology · Salt Lake City, UTNPI 1114077849
Payments from drug & device makers
What this record shows
This record is dominated by education: $497 of the $545 with a category attached, or 91.0%. Johnson & Johnson accounts for 73.5% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $196, 2.5 times the $77 reported in 2020. That places this record below the midpoint for dermatology clinicians in UT, where the typical reported total is $1,056.
Across 9 payments — averaging $60.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$401
- Regeneron Healthcare Solutions, Inc.$96
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$21
- AbbVie$15
- AstraZeneca$14
Across 1 payment — averaging $695.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$695
What the payments were for
- Food & beverage$499%
- Education$49791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 5 | $401 |
| Regeneron Healthcare Solutions, Inc. | 1 | $96 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| AbbVie | 1 | $15 |
| AstraZeneca | 1 | $14 |
How this compares
$545 in reported general payments places this provider in the 40th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 18 | $100,985 |
| Dupixent SyringeDupilumab | 25 | $97,014 |
| Mycophenolic AcidMycophenolate Sodium | 15 | $5,499 |
| Fluorouracil | 67 | $4,636 |
| Clobetasol Propionate | 91 | $3,229 |
| Triamcinolone Acetonide | 130 | $1,414 |
| Hydroxychloroquine Sulfate | 46 | $1,317 |
| MethotrexateMethotrexate Sodium | 35 | $1,039 |
| Doxycycline Monohydrate | 24 | $997 |
| Metronidazole | 27 | $996 |
| Ketoconazole | 68 | $921 |
| Desonide | 31 | $749 |
| Fluocinonide | 31 | $726 |
| Doxycycline Hyclate | 22 | $634 |
| Clindamycin Phosphate | 15 | $614 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Salt Lake City
- Gerald KruegerSalt Lake City$156K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
- Stephanie ZoneSalt Lake City$22K
- Lauren MadiganSalt Lake City$21K
- Elena HadjicharalambousSalt Lake City$9K
- Grace BrummerSalt Lake City$4K
- Megan ProutySalt Lake City$3K
- Michael SotiriouSalt Lake City$3K
- Dev SahniSalt Lake City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.